It would be beneficial to further explore the specific bioactive peptides responsible for the observed anti-AChE and antidiabetic activities. Could the authors elaborate on the potential mechanisms by which these peptides exert their effects? Additionally, are there plans to conduct in vivo studies to validate these findings and assess the bioavailability and efficacy of these bioactive peptides in a physiological context?
